Company: AMTX
Filing Date: 2025-02-12
Form Type: 424B5
Source: 0001437749-25-003485
Chunk: 13

Company: AEMETIS, INC
Filing Date: 2025-02-12
Form: 424B5
Chunk 13
---
 the common stock during the sales period, the limits we set with the distribution agent in any applicable placement notice, and the demand for our common stock during the sales period. Because the price per share of each share sold will fluctuate during the sales period, it is not currently possible to predict the number of shares that will be sold or the gross proceeds to be raised in connection with those sales, and we may not be able to access the full amount available under the sales agreement.

Our inability to access a portion or the full amount available under the sales agreement, in the absence of any other financing sources, could have a material adverse effect on our business. The extent to which we rely on sales under the sales agreement as a source of funding will depend on a number of factors including the prevailing market price of our common stock and the extent to which we are able to secure working capital from other sources. If obtaining sufficient funding from sales under the sales agreement were to prove unavailable or prohibitively dilutive, we will need to secure another source of funding in order to satisfy our working capital needs. Even if we were to receive all of the gross proceeds available under the sales agreement, we may still need additional capital to fully implement our business, operating and development plans. Should the financing we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could be a material adverse effect on our business, operating results, financial condition and prospects.

The common stock offered hereby will be sold in“at the market" offerings,and investors who buy shares at different times will likely pay different prices.

Investors who purchase shares in this offering at different times will likely pay different prices, and so may experience different levels of dilution and different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold in this offering. In addition, there is no minimum or maximum sales price for shares to be sold in this offering. Investors may experience a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.

<div align='center'>S-10</div>

Risks Related to Our Business Generally

We rely on the availability of tax credits, carbon credits, grants, and other regulatory and financial incentives. The expiration, elimination, modification, or reduction of these regulations, credits, and incentives could adversely impact our business.

U.S. and India federal, state, and local governments provide regulations and